Senior Director, AI to Transform Care Partner, International

Introduction to role: The International region is AstraZeneca s largest, most diverse, and fastest-growing region, representing around one-third of total company revenue. Spanning more than 90 countries across five continents, it covers over 70% of the world s population. International is not Rest of World it is Most of World and with that scale comes a profound responsibility to patients, as the burden of non-communicable disease and mortality is disproportionately high across our markets. International is a critical growth engine for AstraZeneca, delivering double-digit growth across all therapy areas and playing a central role in the company s future success. We operate in a complex, rapidly evolving environment and we are doubling down on growth and pipeline delivery to make Ambition 2030 a reality in International. At the heart of this is how we use AI, digital and data to transform our company, accelerate our science and maximize our impact for patients. We are looking for a senior leader to own and scale AI-driven Digital Precision Healthcare across International markets, expanding beyond oncology into a multi-therapy area impact. This role will translate business, medical, and market access priorities into AI-powered care pathway transformation programs, delivering measurable improvements in: earlier patient identification faster and more accurate diagnosis optimized treatment selection continuous patient monitoring The role goes beyond strategy: it requires end-to-end ownership from problem definition to deployment at scale, embedding AI solutions directly into healthcare workflows (EMR, diagnostics, clinical practice). Acting as a central orchestrator, this leader will connect Commercial, Medical, R&D, Market Access, and Diagnostics with external partners (health systems, tech players, AI companies) to deliver scalable, compliant, and outcome-driven solutions across diverse healthcare systems .

Digital & AI to Transform Care : Own and drive the International AI-enabled Digital Precision Healthcare strategy across therapy areas Translate unmet needs into actionable AI roadmaps and prioritized use cases Ensure alignment with Commercial, Medical, R&D and Market Access priorities Care pathway prioritization : Coordinate cross-functional alignment to select priority pathways where digital and AI can improve patient identification, guideline-adherent care, and outcomes at scale: Focus areas: Patient Identification: AI across EMRs, imaging archives, pathology slides to identify patients earlier and with greater precision, multimodal data Pathway Optimization: Programs to transform fragmented care pathways, applying AI to reduce diagnostic delays, cut MDT workload and ensure guideline adherence at scale Diagnosis acceleration and biomarker testing Treatment optimization and decision support Longitudinal patient monitoring Innovative Data Strategy : Collaborate closely with both external partners and internal teams (commercial, medical, and R&D) to optimize data strategies, enabling AstraZeneca to capitalize on emerging technologies AI for RWE Generation: Generate RWE through Transform Care programs to support payer-ready RWE packages to accelerate approval and access Health System Partnerships : Establish and maintain a robust partnership framework with digital health partners, driving successful collaborations and ensuring alignment between AstraZeneca and its external partners Scaling across markets : Establish operating models with Global and Enterprise AI to pilot and scale pathway solutions efficiently, including data sourcing, workflow integration, and stakeholder engagement